Effects of Viral and cytokine delays on dynamics of autoimmunity by Fatehi Chenar, Farzad et al.
mathematics
Article
Effects of Viral and Cytokine Delays on Dynamics
of Autoimmunity
Farzad Fatehi, Yuliya N. Kyrychko and Konstantin B. Blyuss * ID
Department of Mathematics, University of Sussex, Brighton BN1 9QH, UK; F.Fatehi@sussex.ac.uk (F.F.);
Y.Kyrychko@sussex.ac.uk (Y.N.K.)
* Correspondence: k.blyuss@sussex.ac.uk; Tel.: +44-1273-872878
Received: 30 March 2018; Accepted: 24 April 2018; Published: 28 April 2018


Abstract: A major contribution to the onset and development of autoimmune disease is known
to come from infections. An important practical problem is identifying the precise mechanism by
which the breakdown of immune tolerance as a result of immune response to infection leads to
autoimmunity. In this paper, we develop a mathematical model of immune response to a viral
infection, which includes T cells with different activation thresholds, regulatory T cells (Tregs),
and a cytokine mediating immune dynamics. Particular emphasis is made on the role of time delays
associated with the processes of infection and mounting the immune response. Stability analysis of
various steady states of the model allows us to identify parameter regions associated with different
types of immune behaviour, such as, normal clearance of infection, chronic infection, and autoimmune
dynamics. Numerical simulations are used to illustrate different dynamical regimes, and to identify
basins of attraction of different dynamical states. An important result of the analysis is that not only
the parameters of the system, but also the initial level of infection and the initial state of the immune
system determine the progress and outcome of the dynamics.
Keywords: mathematical model; immune response; autoimmunity; time delays
1. Introduction
An immune system can only be viewed as effective when it can robustly identify and destroy
pathogen-infected cells, while also distinguishing such cells from healthy cells. In the case of breakdown
of immune tolerance, the immune system fails to discriminate between self-antigens and foreign
antigens, which results in autoimmune disease, i.e., undesired destruction of healthy cells. Under
normal conditions, once foreign epitopes are presented on antigen presenting cells (APCs) to T cells,
this results in the proliferation of T cells and eliciting their effector function. While this mechanism is
responsible for a successful clearance of infection, cross-reactivity between epitopes associated with
foreign and self-antigens can lead to a T cell response against healthy host cells [1,2].
For many autoimmune diseases, the disease occurs in a specific organ or part of the body, such as
retina in uveitis, central nervous system in multiple sclerosis, or pancreatic β-cells in type-1 diabetes [3–5].
It is extremely difficult to identify the specific causes of autoimmunity in individual patients, as it usually
has contributions from a number of internal and external factors, including a genetic predisposition,
age, previous immune challenges, exposure to pathogens etc., [6–9]. Even though genetic predisposition
is known to play a very significant role, it is believed that some additional environmental triggers are
required for the onset of autoimmunity, and these are usually represented by infections [10,11]. A very
recent work has experimentally identified a gut bacterium that, when present in mice and humans,
can migrate to other parts of the body, facilitating subsequent triggering of autoimmune disease in those
organs [12]. Various mechanisms of onset of pathogen-induced autoimmune disease have been identified,
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including bystander activation [13] and molecular mimicry [14,15], which is particularly important in the
context of autoimmunity caused by viral infections.
A number of mathematical models have looked into dynamics of onset and development of
autoimmune disease. Segel et al. [16] analysed interactions between effector and regulatory T cells
in the context of T cell vaccination, without explicitly specifying possible causes of autoimmunity.
Similar models were later studied by Borghans et al. [17,18] who demonstrated possible onset of
autoimmune state, defined as stable above-threshold oscillations in the number of autoreactive
cells, as a result of interactions between regulatory and autoreactive T cells. León et al. [19–21]
and Carneiro et al. [22] have studied interactions between different T cells, with an emphasis on the
suppressing role of regulatory T cells in the dynamics of immune response and control of autoimmunity.
Alexander and Wahl [23] have also looked into the role of regulatory T cells, in particular focusing
on their interactions with professional APCs and effector cells for the purpose of controlling immune
response. Iwami et al. [24,25] explicitly included a separate compartment representing the viral
population in their models of immune response, and showed that the functional form of the growth
function for susceptible host cells can have a significant effect on the resulting immune dynamics.
Despite being able to explain the emergence of autoimmunity as a by-product of immune response to
infection, these models were not able to exhibit another practically important dynamical regime of
normal viral clearance. For the case of pathogen-induced autoimmunity arising through bystander
activation, Burroughs et al. [26–28] have developed a model that investigates interactions between T
cells and interleukin-2 (IL-2), an important cytokine, in mediating the onset of autoimmunity.
Among various parts of the immune system involved in coordinating an effective immune
response, a particularly significant role is known to be played by the T cells, with experimental
evidence suggesting that regulatory T cells are vitally important for controlling autoimmunity [29–32].
To account for this fact in mathematical models, Alexander and Wahl [23] and Burroughs et al. [26,27]
have explicitly included a separate compartment for regulatory T cells that are activated by
autoantigens and suppress the activity of autoreactive T cells. Another framework for modelling
the effects of T cells on autoimmune dynamics is by using the idea that T cells have different or
tunable activation thresholds (TAT), which result in different immune functionality of the same T cells,
and also allow T cells to adjust their response to simulation by autoantigens. This approach was
proposed for the analysis of the peripheral and central T cell dynamics [33–35], it has also been used to
study differences in activation/response thresholds that are dependent on the activation state of the
T cell [36]. Murine and human experiments have confirmed that activation of T cells can indeed change
dynamically during their circulation [37–40]. To model this feature, van den Berg and Rand [41],
and Scherer et al. [42] developed stochastic models for the tuning of activation thresholds.
Blyuss and Nicholson [43,44] have proposed a mathematical model of autoimmunity resulting
from immune response to a viral infection through a mechanism of molecular mimicry. This model
explicitly includes the virus population and two types of T cells with different activation thresholds,
and it also accounts for a biologically realistic scenario where infection and autoimmune response can
occur in different organs of the host. Besides the normal viral clearance and chronic infection, in some
parameter regime the model also exhibits an autoimmune state characterised by stable oscillations in
the amounts of cell populations. From a clinical perspective, such behaviour is to be expected, as it is
associated with relapses and remissions that have been observed in a number of autoimmune diseases,
such as autoimmune thyroid disease, MS, and uveitis [45–47]. One deficiency of this model is the fact
that the oscillations associated with autoimmune regime can only occur if the amount of free virus and
the number of infected cells are also exhibiting oscillations, while in clinical and laboratory settings,
autoimmunity usually occurs after the initial infection has been fully cleared. To overcome this limitation,
Fatehi et al. [48] have recently developed a more advanced model that also includes regulatory T cells
and cytokines, which has allowed the authors to obtain a more realistic representation of immune
response and various dynamical regimes. A particularly important practical insight provided by this
model is the observation that it is not only the system parameters, but also the initial level of infection
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and the initial state of the immune system, that determine whether the host will just successfully clear
the infection, or will proceed to develop autoimmunity. Approaching the same problem from another
perspective, Fatehi et al. [49] have investigated the role of stochasticity in driving the dynamics of immune
response and determining which of the immune states is more likely to be attained. The authors have
also determined an experimentally important characterisation of autoimmune state, as provided by the
dependence of variance in cell populations on various system parameters.
In this paper, we develop and analyse a model of autoimmune dynamics, with particular focus on
the role of time delays associated with different aspects of immune response, as well as an inhibiting
effect of regulatory T cells on secretion of IL-2. In the next section, we introduce the model and discuss
its basic properties. Section 3 contains systematic analysis of all steady states, including conditions for
their feasibility and stability. Section 4 contains a bifurcation analysis of the model and demonstrates
various types of behaviour that the system exhibits depending on parameters and initial conditions,
which includes identification of attraction basins of various states. The paper concludes in Section 5
with the discussion of results.
2. Model Derivation
To understand how interactions between different parts of the immune system and the cytokine can
lead to autoimmunity, we consider a model illustrated in a diagram shown in Figure 1. In this model,
unlike earlier work of Blyuss and Nicholson [43,44], we consider a situation where a viral infection and
possible autoimmunity occur in the same organ of the host. The healthy host cells, whose number is
denoted by A(t), in the absence of infection are assumed to grow logistically with linear growth rate r and
carrying capacity N, and they acquire infection at rate β from the infected cells F(t). Since experimental
evidence suggests that antibodies play a secondary role compared to T cells [50], and autoimmunity can
develop even in the absence of B cells [51], we do not include antibody response in the model, but focus
solely on the dynamics of T cell populations. Naïve (inactivated) T cells Tin(t) are assumed to be in
homeostasis [24,25,43], and once they are activated through interaction with infected cells, which occurs
at rate α, a proportion p1 of them will go on to differentiate into additional regulatory T cells, a fraction
p2 will become normal activated T cells Tnor(t) able to destroy infected cells at rate µF upon recognition
of foreign antigen present on their surface. The remaining proportion of (1− p1 − p2) of T cells will
become autoreactive T cells Taut(t) that, in light of their lower activation threshold will be eliminating
both infected cells and healthy host cells at rate µa due to the above-mentioned cross-reactivity between
some epitopes in self- and foreign antigens. Regulatory T cells Treg(t) are assumed to be in their own
homeostasis [52], and their main contribution to immune dynamics lies in suppressing autoreactive T cells
at rate δ1. To reduce the dimensionality of the model, it is assumed that the process of viral production is
occurring very fast compared to other characteristic timescales of the model, thus the viral population can
be represented by its quasi-steady-state approximation, i.e., it is taken to be proportional to the number of
infected cells, and this eliminates the need for a separate compartment for free virus.
A number of different cytokines mediate immune response to infection, and in the context of T cell
dynamics, a particular important role is played by interleukin 2 (IL-2), represented by the variable I(t) in
the model, which acts to enhance the proliferation of T cells, which, in turn, secrete further IL-2. One of
the actions of regulatory T cells is to suppress the expression of IL-2 [53], which is only produced by
the activated T cells, but not by the regulatory T cells [54,55]. To represent this mathematically, we will
assume that Tnor and Taut produce IL-2 at rates σ1 and σ2, and conversely, IL-2 enhances proliferation of
Treg, Tnor and Taut at rates ρ1, ρ2, and ρ3. We include in the model suppression of IL-2 by regulatory T cells
at rate δ2, in a manner similar to Burroughs et al. [28].
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Figure 1. A schematic diagram of immune response to infection. Blue indicates host cells (susceptible
and infected), red denotes different T cells (naïve, regulatory, normal activated, and autoreactive
T cells), yellow shows cytokines (interleukin 2). τi inside each of the subnetworks shows the time delay
associated with that process.
While the production of new virus particles by infected cells is assumed to be fast, we explicitly
include in the model time delay τ1 associated with the actual process of infection, which includes
multiple stages of the eclipse phase of viral life cycle, such as virus attachment, cell penetration and
uncoating [56,57]. We also include the time delay τ2 associated with simulation and proliferation of
T cells by IL-2, and the time delay τ3 between antigen encounter and resulting T cell expansion [58].
With the above assumptions, the complete model takes the form
dA
dt
= rA
(
1− A
N
)
− βAF− µaTaut A,
dF
dt
= βA (t− τ1) F (t− τ1)− dFF− µFTnorF− µaTautF,
dTin
dt
= λin − dinTin − αTinF,
dTreg
dt
= λr − drTreg + p1αTin (t− τ3) F (t− τ3) + ρ1 I (t− τ2) Treg (t− τ2) ,
dTnor
dt
= p2αTin (t− τ3) F (t− τ3)− dnTnor + ρ2 I (t− τ2) Tnor (t− τ2) ,
dTaut
dt
= (1− p1 − p2)αTin (t− τ3) F (t− τ3)− daTaut − δ1TregTaut + ρ3 I (t− τ2) Taut (t− τ2) ,
dI
dt
= σ1Tnor + σ2Taut − δ2Treg I − di I.
Introducing non-dimensional variables
tˆ = rt, A = NAˆ, F = NFˆ, Tin =
λin
din
Tˆin, Treg =
λin
din
Tˆreg,
Tnor =
λin
din
Tˆnor, Taut =
λin
din
Tˆaut, I =
λin
din
Iˆ,
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where
βˆ =
βN
r
, µˆa =
µaλin
rdin
, dˆF =
dF
r
, µˆF =
µFλin
rdin
, dˆin =
din
r
, αˆ =
αN
r
,
λˆr =
λrdin
λinr
, dˆr =
dr
r
, dˆn =
dn
r
, dˆa =
da
r
, ρˆi =
ρiλin
rdin
, i = 1, 2, 3,
δˆ1 =
δ1λin
rdin
, δˆ2 =
δ2λin
rdin
, σˆ1 =
σ1
r
, σˆ2 =
σ2
r
, dˆi =
di
r
,
yields a rescaled model
dA
dt
= A (1− A)− βAF− µaTaut A,
dF
dT
= βA (T − τ1) F (T − τ1)− dFF− µFTnorF− µaTautF,
dTin
dT
= din (1− Tin)− αTinF,
dTreg
dT
= λr − drTreg + p1αTin (T − τ3) F (T − τ3) + ρ1 I (T − τ2) Treg (T − τ2) ,
dTnor
dT
= p2αTin (T − τ3) F (T − τ3)− dnTnor + ρ2 I (T − τ2) Tnor (T − τ2) ,
dTaut
dT
= (1− p1 − p2)αTin (T − τ3) F (T − τ3)− daTaut − δ1TregTaut + ρ3 I (T − τ2) Taut (T − τ2) ,
dI
dT
= σ1Tnor + σ2Taut − δ2Treg I − di I,
(1)
where all hats in variables and parameters have been dropped for simplicity of notation, and all
parameters are assumed to be positive. It is easy to show that this system is well-posed, i.e., solutions
with non-negative initial conditions remain non-negative for all t ≥ 0.
As a first step in the analysis of model (1), we look at its steady states
S∗ =
(
A∗, F∗, T∗in, T
∗
reg, T
∗
nor, T
∗
aut, I
∗
)
,
that can be found by equating to zero the right-hand sides of Equation (1) and solving the resulting
system of algebraic equations, deferring the discussion of conditionally stable steady states to Section 3.
First, we consider a situation where there are no infected cells at a steady state, i.e., F∗ = 0,
which immediately implies T∗in = 1. In this case, there are four possible combinations of steady
states depending on whether T∗nor and T∗aut are each equal to zero or positive. If T∗nor = T∗aut = 0,
there are two steady states
S∗1 =
(
0, 0, 1,
λr
dr
, 0, 0, 0
)
, S∗2 =
(
1, 0, 1,
λr
dr
, 0, 0, 0
)
,
of which S∗1 is always unstable, and S
∗
2 is a disease-free conditionally stable steady state.
For T∗nor 6= 0 and T∗aut = 0, we again have two steady states
S∗3 =
(
0, 0, 1,
λrρ2
ρ2dr − ρ1dn , T
∗
nor, 0,
dn
ρ2
)
, S∗4 =
(
1, 0, 1,
λrρ2
ρ2dr − ρ1dn , T
∗
nor, 0,
dn
ρ2
)
,
where T∗nor =
dn (λrδ2ρ2 + didrρ2 − didnρ1)
ρ2σ1(ρ2dr − ρ1dn) , but they are both unstable for any values of parameters.
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In the case when T∗nor = 0 and T∗aut 6= 0, we have two further steady states S∗5 and S∗6 ,
S∗5 =
0, 0, 1, T∗reg, 0,
(
di + δ2T∗reg
) (
da + δ1T∗reg
)
ρ3σ2
,
da + δ1T∗reg
ρ3
 ,
S∗6 =
A∗, 0, 1, T∗reg, 0,
(
di + δ2T∗reg
) (
da + δ1T∗reg
)
ρ3σ2
,
da + δ1T∗reg
ρ3
 ,
where A∗ = 1−
µa
(
di + δ2T∗reg
) (
da + δ1T∗reg
)
ρ3σ2
, and
T∗reg =
drρ3 − ρ1da ±
√
(drρ3 − ρ1da)2 − 4ρ1δ1λrρ3
2ρ1δ
.
The steady state S∗5 has A∗ = 0, which implies the death of host cells, whereas the steady state S∗6
corresponds to an autoimmune regime. The steady state S∗7 with T∗nor 6= 0 and T∗aut 6= 0 exists only for
a particular combination of parameters, namely, when
δ1ρ
2
2λr = (ρ3dn − ρ2da)(ρ2dr − ρ1dn),
and is always unstable. Finally, when F∗ 6= 0, the system (1) can have a steady state S∗8 with all of its
components being positive, but it does not appear possible to find a closed form expression for this state.
In summary, besides the unconditionally unstable steady states, the model (1) has at most for
conditionally stable steady states: the disease-free steady state S∗2 , the steady state with the death of
host cells S∗5 , the autoimmune steady state S∗6 , and the persistent or chronic steady state S∗8 .
3. Stability Analysis of the Steady States
3.1. Stability Analysis of the Disease-Free Steady State
Linearising the system (1) near the disease-free steady state S∗2 yields the following equation for
characteristic roots λ
λ+ dF − βe−λτ1 = 0. (2)
If dF < β, the above equation always has a real positive root for any value τ1 ≥ 0, implying that the
disease-free steady state is always unstable for any value of the time delays. If, however, the condition
dF > β holds, the disease-free steady state is stable for τ1 = 0. To find out whether it can lose stability
for τ1 > 0, we look for solutions of Equation (2) in the form λ = iω. Separating real and imaginary
parts yields
dF = β cos(ωτ1),
ω = −β sin(ωτ1).
Squaring and adding these two equations gives the following equation for potential Hopf
frequency ω
ω2 + d2F − β2 = 0.
since dF > β, this equation does not have real roots for ω, suggesting that there can be no roots of the
form λ = iω of the characteristic Equation (2). This implies that in the case dF > β the disease-free
steady state S∗2 is stable for all values of the time delay τ1 ≥ 0.
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3.2. Stability Analysis of the Death, Autoimmune and Chronic Steady States
The steady state S∗5 (respectively, S∗6) is stable if
P <
da + δ1T∗reg
ρ3
<
dn
ρ2
, (3)
and all roots of the following equation have negative real part
∆(τ2,λ) = p2(λ)e−2λτ2 + p1(λ)e−λτ2 + p0(λ) = 0, (4)
where
p2(λ) =
ρ1
(
da + δ1T∗reg
)2
ρ3
(
λ+ 2di + δ2T∗reg
)
,
p1(λ) =−
(
da + δ1T∗reg
)
ρ3
{
(ρ1 + ρ3)λ
2 +
[
ρ1
(
di + da + δ1T∗reg
)
+ ρ3
(
dr + 2di + 2δ2T∗reg
)]
λ
+ di(ρ1da + 2drρ3) + δ2T∗reg
(
−ρ1δ1T∗reg + 2drρ3
) }
,
p0(λ) = (λ+ dr)
(
λ+ di + δ2T∗reg
) (
λ+ da + δ1T∗reg
)
,
and
P =

σ2
µa
(
di + δ2T∗reg
) , for S∗5 ,
σ2 (β− dF)
µa (1+ β)
(
di + δ2T∗reg
) , for S∗6 .
This steady state undergoes a steady-state bifurcation if
da + δ1T∗reg
ρ3
= P, or
da + δ1T∗reg
ρ3
=
dn
ρ2
, or δ1ρ1
(
T∗reg
)2
= λrρ3. (5)
For τ2 = 0 these steady states are stable if T∗reg satisfies (3) and
δ1ρ1
(
T∗reg
)2
> λrρ3,
a5
(
T∗reg
)5
+ a4
(
T∗reg
)4
+ a3
(
T∗reg
)3
+ a2
(
T∗reg
)2
+ a1T∗reg + a0 > 0,
(6)
where
a5 = −δ1δ2(δ1ρ1 − δ2ρ1 + δ2ρ3), a4 = daδ2(δ2ρ2 − δ1ρ1 − δ2ρ3)− diδ1(δ1ρ1 − δ2ρ1 + 2δ2ρ3),
a3 = −diδ1(daρ1 + diρ3) + dadiδ2(ρ1 − 2ρ3) + λrδ2(δ1ρ1 + δ2ρ3),
a2 = −dad2i ρ3 + λrδ2(daρ1 + 2diρ3), a1 = λrρ3(d2i + δ2λr), a0 = diρ3λ2r .
To investigate whether stability can be lost for τ2 > 0, we use an iterative procedure described
in [59,60] to determine a function F(ω), whose roots give the Hopf frequency associated with purely
imaginary roots of Equation (4). Substituting λ = iω into Equation (4), we define ∆(1)(τ2,λ) as
∆(1)(τ2,λ) = p0(iω)∆(τ2, iω)− p2(iω)e−2iωτ2∆(τ2, iω) = p(1)0 (iω) + p(1)1 (iω)e−iωτ2 ,
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where
p(1)0 (iω) =|p0(iω)|2 − |p2(iω)|2,
p(1)1 (iω) =p0(iω)p1(iω)− p1(iω)p2(iω),
and the bar denotes the complex conjugate. If we define
F(ω) =
∣∣∣p(1)0 (iω)∣∣∣2 − ∣∣∣p(1)1 (iω)∣∣∣2,
then ∆(τ2, iω) = 0 whenever ω is a root of F(ω) = 0. The function F(ω) has the explicit form
F(ω) = ω12 + b10ω10 + b8ω8 + b6ω6 + b4ω4 + b2ω2 + b0,
with
b0 =
(
δ1da + T∗reg
)4
ρ34
(
di + δ2T∗reg
) (
2T∗regδ1ρ1 + daρ1 − drρ3
)
[ (
di + δ2T∗reg
)
(daρ1 + 3drρ3) + 2diρ1
(
da + δ1T∗reg
) ]
[
ρ1
(
da + δ1T∗reg
) (
2di + δ2T∗reg
)
− drρ3
(
di + δ2T∗reg
) ]2
.
The explicit formulae for other coefficients of F(ω) can be found in Appendix A. Introducing
s = ω2, the equation F(ω) = 0 can be equivalently rewritten as follows,
h(s) = s6 + b10s5 + b8s4 + b6s3 + b4s2 + b2s + b0 = 0. (7)
Without loss of generality, suppose that Equation (7) has six distinct positive roots denoted by s1,
s2, ... , s6, which means that the equation F(ω) = 0 has six positive roots
ωi =
√
si, i = 1, 2, ..., 6.
Substituting λk = iωk into Equation (4) gives
τk,j =
1
ωk
arctan
 ωk ((ρ1 + ρ3)ω4k + f2ω2k + f0)(
ρ3Z− drρ1 − ρ23 I∗ − ρ1δ2T∗reg
)
ω4k + g2ω
2
k + g0
+ jpi
 ,
for k = 1, 2, ..., 6, j = 0, 1, 2, ..., where
f0 =− ρ12ρ32 I∗3Z− ρ1ρ3 (2ρ1 + 3ρ3) I∗2Z2 + ρ1ρ3T∗reg (−δ1ρ1 + 3δ2ρ1 + δ2ρ3) I∗2Z
− T∗reg2δ22ρ12ρ3 I∗2 − T∗regδ1ρ1ρ3 I∗Z2 + drρ3
(
−δ1ρ1T∗reg + drρ3
)
I∗Z
+ dr
(
−T∗regδ1ρ1 + 2drρ3
)
Z2,
f2 =− ρ12ρ3 I∗2 + ρ32 I∗Z + (ρ1 + 2ρ3) Z2 + ρ1T∗reg (δ1 − δ2) Z− dr
(
T∗regδ2ρ1 − drρ3
)
,
g0 = ρ12ρ32 I∗3
(
2Z2 − 3T∗regδ2Z + T∗reg2δ22
)
+ ρ1ρ3
(
−2T∗regδ1ρ1 + 3drρ3
)
I∗2Z2
+ ρ1ρ3δ2T∗reg
(
T∗regδ1ρ1 − drρ3
)
I∗2Z + drρ3
(
T∗regδ1ρ1 − 2drρ3
)
I∗Z2,
g2 = ρ3 I∗
(
ρ1
2ρ3 I∗2 − ρ12 I∗Z− 2ρ3Z2 − T∗regδ1ρ1Z− dr2ρ3
)
− ρ1
(
dr + δ1T∗reg
)
Z2
+ dr
(
−T∗regδ1ρ1 + T∗regδ2ρ1 + drρ3
)
Z,
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and
I∗ =
da + δ1T∗reg
ρ3
, Z = di + δ2T∗reg.
This allows us to find
τ∗ = τk0,0 = min1≤k≤6
{τk,0}, ω0 = ωk0 ,
as the first time delay for which the roots of the characteristic Equation (4) cross the imaginary axis.
To determine whether these steady states actually undergo a Hopf bifurcation at τ2 = τ∗, we have to
compute the sign of dRe[λ(τ∗)]/dτ2. For τ = τ∗, λ(τ∗) = iω0, and we also define s0 = ω20.
Lemma 1. Suppose h′(s0) 6= 0 and p(1)0 (iω0) 6= 0. Then the following transversality condition holds
sgn
{
d Re(λ)
d τ2
∣∣∣∣
τ2=τ∗
}
= sgn[p(1)0 (iω0)h
′(s0)].
Proof. Considering pj(iω0) = xj(ω0) + iyj(ω0) for j = 0, 1, 2, we have
p(1)0 (iω0) =x
2
0 + y
2
0 − x22 − y22,
p(1)1 (iω0) =(x0x1 + y0y1 − x1x2 − y1y2) + (x0y1 + x2y1 − x1y0 − x1y2)i,
where all xj and yj are expressed in terms of system parameters and steady state values of the variables.
Substituting these expressions into ∆(τ2, iω0) = 0 and ∆(1)(τ2, iω0) = 0, and then separating real and
imaginary parts gives
x2 cos(2ω0τ∗) + y2 sin(2ω0τ∗) + x1 cos(ω0τ∗) + y1 sin(ω0τ∗) = −x0,
y2 cos(2ω0τ∗)− x2 sin(2ω0τ∗) + y1 cos(ω0τ∗)− x1 sin(ω0τ∗) = −y0,
(x0x1 + y0y1 − x1x2 − y1y2) cos(ω0τ∗) + (x0y1 + x2y1 − x1y0 − x1y2) sin(ω0τ∗)
= −x20 − y20 + x22 + y22,
(x0y1 + x2y1 − x1y0 − x1y2) cos(ω0τ∗)− (x0x1 + y0y1 − x1x2 − y1y2) sin(ω0τ∗) = 0.
Solving this system of equations provides the values of sin(ω0τ∗), cos(ω0τ∗), sin(2ω0τ∗),
and cos(2ω0τ∗). Taking the derivative of Equation (4) with respect to τ2, one finds(
d λ
d τ2
)−1
=
p′2(λ)e−2λτ2 + p′1(λ)e
−λτ2 + p′0(λ)
λ
(
2p2(λ)e−2λτ2 + p1(λ)e−λτ2
) − τ2
λ
.
Hence,(
d Re(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1
= Re
{
p′2(λ)e−2λτ2 + p′1(λ)e
−λτ2 + p′0(λ)
λ
(
2p2(λ)e−2λτ2 + p1(λ)e−λτ2
) }
τ2=τ∗
− Re
{τ2
λ
}
τ2=τ∗
= Re
{
p′2(iω0)e−2iω0τ2 + p′1(iω0)e
−iω0τ2 + p′0(iω0)
iω0
(
2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2
) }
=
1
ω0
Im
{
p′2(iω0)e−2iω0τ2 + p′1(iω0)e
−iω0τ2 + p′0(iω0)
2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2
}
=
1
Λω0
[
− x2x′2 − y2y′2 + x0x′0 + y0y′0 + (x2y′1 − y2x′1 + x0y′1 − x′1y0) sin(ω0τ∗)
+ (x0x′1 + y0y
′
1 − x′1x2 − y′1y2) cos(ω0τ∗) + (x2y′0 − x′0y2 + x0y′2 − x′2y0) sin(2ω0τ∗)
+ (x0x′2 + y0y′2 − x′0x2 − y′0y2) cos(2ω0τ∗)
]
,
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where
Λ =
∣∣∣2p2(iω0)e−2iω0τ2 + p1(iω0)e−iω0τ2 ∣∣∣2 .
Substituting the values of sin(ω0τ∗), cos(ω0τ∗), sin(2ω0τ∗), and cos(2ω0τ∗) found earlier gives(
d Re(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1
=
1
Λω0
F′(ω0)
2 p(1)0 (iω0)
=
h′(s0)
Λ p(1)0 (iω0)
.
Therefore
sgn
{
d Re(λ)
d τ2
∣∣∣∣
τ2=τ∗
}
= sgn

(
d Re(λ)
d τ2
∣∣∣∣
τ2=τ∗
)−1 = sgn
{
h′(s0)
Λ p(1)0 (iω0)
}
= sgn[p(1)0 (iω0)h
′(s0)],
which completes the proof.
We can now formulate the main result concerning stability of the steady states S∗5 and S∗6 .
Theorem 1. Suppose the value of T∗reg satisfies conditions (3) and (6). If Equation (7) has at least one positive
root s0, and p
(1)
0 (iω0)h
′(s0) > 0 with ω0 =
√
s0, then the steady state S∗5 (respectively, S∗6) is stable for
0 ≤ τ2 < τ∗, unstable for τ2 > τ∗, and undergoes a Hopf bifurcation at τ2 = τ∗.
Since T∗reg satisfies conditions (3) and (6), the steady state S∗5/S∗6 is stable for τ2 = 0. Lemma 1 then
ensures that τ∗ is the first positive value of the time delay τ2, for which the roots of the characteristic
Equation (4) cross the imaginary axis with positive speed. Hence, the steady state S∗5/S∗6 is stable for
0 ≤ τ2 < τ∗, unstable for τ2 > τ∗, and undergoes a Hopf bifurcation at τ2 = τ∗.
Remark 1. A similar result can be formulated for a subcritical Hopf bifurcation of the steady state S∗5/S∗6 at
some higher value of τ2.
The only remaining steady state is the persistent (chronic) equilibrium S∗8 with all of its components
being positive. Since it did not prove possible to find a closed form expression for this steady state,
its stability also has to be studied numerically.
4. Numerical Stability Analysis and Simulations
To investigate the role of different parameters in the dynamics of model (1), in this section we perform
a detailed numerical bifurcation analysis and simulations of this model. Stability of different steady states
is determined numerically by computing the largest real part of the characteristic eigenvalues, which is
achieved by using a pseudospectral method implemented in a traceDDE suite in MATLAB [61].
Analytical results from the previous section suggest that at β = dF, the disease-free steady state
S∗2 undergoes a transcritical bifurcation. For β < dF, the disease-free steady state S∗2 is stable, and
the chronic steady state is infeasible. On the contrary, when β > dF, the disease-free steady state
S∗2 is unstable, and in this case it makes sense to investigate stability of the chronic steady state.
Therefore, these two cases are considered separately, and as a first step we fix the baseline values
as given in Table 1. For this choice of parameters, we have dF − β > 0, implying that S∗2 is always
stable, and Figure 2 illustrates how the stability of S∗5 and S∗6 is affected by parameters. This figure
indicates that the steady states S∗5 and S∗6 are only biologically feasible if the regulatory T cells do
not grow too rapidly and do not clear autoreactive T cells too quickly. Importantly, Figure 2 shows
that the value of the rate δ2 of clearance of IL-2 by regulatory T cells does not have any effect on the
thresholds of λr and δ1, where the steady states S∗5 and S∗6 lose their feasibility. Moreover, if λr and δ1
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are small, then increasing the rate δ2 at which Tregs inhibit the production of IL-2 makes S∗6 become
unfeasible, resulting in a stable steady state S∗5 , which has the zero population of host cells A. On the
other hand, the steady state S∗6 associated with autoimmune responses is favoured for higher values
of δ1 and λr. In the case stable periodic solutions around these steady states, increasing δ2 results in
the disappearance of oscillations and stabilisation of the associated steady state. At the intersection
of the lines of Hopf bifurcation and the steady-state bifurcation, as determined by Theorem 1 and
conditions (5), one has the co-dimension two fold-Hopf (also known as zero-Hopf or saddle-node
Hopf) bifurcation [62].
Table 1. Table of parameter values.
Parameter Value Parameter Value
β 1 ρ3 2
µa 20 dn 1
dF 1.1 da 0.001
µF 6 δ1 0.0025
din 1 δ2 0.001
α 0.4 σ1 0.15
λr 3 σ2 0.33
dr 0.4 di 0.6
p1 0.4 τ1 1.4
p2 0.4 τ2 0.6
ρ1 10 τ3 0.6
ρ2 0.8
Figure 2. (a) Regions of feasibility and stability of the steady states S∗5 and S∗6 with parameter values
from Table 1; and (b) with µa = 10. Black and red curves indicate the boundaries of feasibility and the
steady-state bifurcation, whereas dashed lines (blue/brown) show the boundaries of Hopf bifurcation
of the steady states S∗5 and S∗6 , respectively, with ‘fH’ indicating the fold-Hopf bifurcation. The first digit
of the index refers to S∗5 , while the second corresponds to S∗6 , and they indicate that in that parameter
region the respective steady state is unfeasible (index is ‘0’), stable (index is ‘1’), unstable via Hopf
bifurcation with a periodic solution around this steady state (index is ‘2’), or unstable via a steady-state
bifurcation (index is ‘3’). In all plots, the condition β < dF holds, so the disease-free steady state S∗2 is
also stable.
Since our earlier analysis showed that stability of the steady states S∗5/S∗6 is affected by the time
delay τ2, in Figure 3 we consider stability of these equilibria depending on τ2 and the rate δ2. For the
steady state S∗5 , if the effect of IL-2 on promoting proliferation of T cells is fast (i.e., τ2 is small), there is
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a large range of δ2, starting with some very low values, for which S∗5 is stable. Increasing the time
delay τ2 results in the Hopf bifurcation of this steady state as described in Theorem 1. One should note
that for intermediate values of δ2, the steady state S∗5 undergoes stability switches, whereby increasing
the delay τ2 further results in a subcritical Hopf bifurcation, which stabilises S∗5 , but after some
number of such stability switches eventually the steady state S∗5 is unstable. For higher still values
of δ2, the steady state S∗5 remains stable for an entire range of τ2 values, and the only way to lose its
stability is via a steady state bifurcation as given by (5). In the case of autoimmune steady state S∗6 ,
the situation is somewhat different in that increasing δ2 beyond some critical values makes this steady
state biologically infeasible. At the same time, for an entire range of δ2 values where it is feasible, this
steady state exhibits a single loss of stability through a Hopf bifurcation for some critical value of the
time delay τ2, in agreement with Theorem 1.
Figure 3. Stability of the steady states S∗5 (a), and S∗6 (b) with parameter values from Table 1. White area
shows the region where the steady state S∗6 is infeasible. Colour code denotes max[Re(λ)] for the steady
states when they are feasible. In all plots the condition dF > β holds, so the disease-free steady state S∗2
is stable. Basins of attraction of different steady states depending on the initial conditions (c), with other
initial conditions specified in (8), and parameter values from Table 1, except for τ2 = 18. Cyan and
pink areas are the basins of attraction of S∗2 and S∗6 , respectively.
As mentioned earlier, for parameter values used in Figure 3, the disease-free steady state S∗2 is
stable. Hence, the system exhibits a bi-stability between a disease-free state and either stable steady
states S∗5/S∗6 , or periodic solutions around these steady states. To investigate this bi-stability, we choose
parameter values as in Table 1 except for τ2 = 18, which corresponds to a stable steady state S∗6 , and
we fix initial conditions for state variables as follows,
(A(0), Tin(0), Tnor(0), Taut(0), I(0)) = (0.9, 0.8, 0, 0, 0), (8)
except for initial amounts of infected cells and regulatory T cells that are allowed to vary. Figure 3c
illustrates the bi-stability between S∗2 and S∗6 in terms of their basins of attraction. It is worth noting
that recently significant research in approximation theory and meshless interpolation has focused on
developing techniques for detection and analysis of attraction basins [63–68]. Figure 3c suggests that
for very large initial amounts of regulatory T cells, the system converges to the disease-free steady
state. It also indicates that if the initial amount of infected cells is very small or is bigger than some
specific value, then the infection will be cleared. Interestingly, increasing the initial amount of the
regulatory T cells results in a larger range of initial amounts of infection, for which the system tends to
a stable autoimmune state S∗6 . In Figure 3b we discovered that increasing τ2 makes the autoimmune
steady state S∗6 undergo a Hopf bifurcation, in which case the system will exhibit a bi-stability between
stable S∗2 and a periodic solution around S∗6 . Our numerical investigation suggests that the shape of
basins of attraction in this case is qualitatively similar to that shown in Figure 3c, with the basin of
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attraction of the stable steady state S∗6 being replaced by the basin of attraction of the periodic solution
around this steady state.
Figure 4 shows temporary evolution of the system (1) in the regime of bi-stability between a stable
disease-free steady state and a stable autoimmune steady state S∗6 (similar pattern of behaviour is
exhibited in the case of bi-stability between S∗2 and S∗5). It also illustrates how the system develops a
periodic solution around the steady state S∗6 for a higher value of τ2. Periodic oscillations around the
steady state S∗6 biologically correspond to a genuine autoimmune state: after the initial infection is
cleared, the system exhibits sustained endogenous oscillations, characterised by periods of significant
reduction in the number of organ cells through a negative action of autoreactive T cells, separated
by periods of quiescence. This type of behaviour is often observed in clinical manifestations of
autoimmune disease [44–47]. This result has substantial biological significance as effectively it suggests
that even for the same kinetic parameters of immune response, the ultimate state of the system,
which can be either a successful clearance of infection without lasting consequences, or progression
to autoimmunity, also depends on the strength of the initial infection and of the initial state of the
immune system, as represented by the initial number of regulatory T cells.
Figure 4. Numerical solutions of the model with parameters values from Table 1, except for τ2 = 18.
(a,b) Stable disease-free steady state S∗2 for F(0) = 0.18, and Treg(0) = 100. (c,d) Transient oscillations
settling on a stable steady state S∗6 for F(0) = 0.18, and Treg(0) = 10. (e,f) Autoimmune dynamics
represented by periodic oscillations around the steady state S∗6 for τ2 = 32, F(0) = 0.18, and Treg(0) = 10.
Next we consider a situation where β > dF, so the disease-free steady state is unstable, and the
system can have three steady states S∗5 , S∗6 and S∗8 . Our earlier results [48] suggest that in the case
where regulatory T cells do not inhibit the production of IL-2, i.e., for δ2 = 0, the steady state S∗6 is
stable. Figure 5 shows regions of feasibility and stability of these steady states depending on δ2 and τ2
in this case. One observes that S∗5 and S∗6 , whose stability boundaries are determined by Theorem 1,
exhibit the same behaviour as in Figure 3, namely, for S∗5 increasing τ2 causes multiple stability switches
for smaller values of δ2, and the steady state is unstable for very small δ2 and stable for large δ2; in
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contrast, S∗5 exhibits a single loss of stability via Hopf bifurcation at some critical value of the time
delay τ2, which itself increases with δ2. Behaviour of S∗8 is similar to that of S∗5 in that there are multiple
stability switches for increasing value of τ2 and small to intermediate values of δ2, while for high values
of δ2, the chronic steady state S∗8 is stable for all values of τ2. Figure 5d divides the δ2-τ2 plane into
different regions based on feasibility and stability of these steady states and shows that increasing δ2
makes the autoimmune steady state S∗6 infeasible. In other regions, the system can exhibit a bi-stability
between a stable steady state S∗8 and either a stable steady state S∗5 , or a periodic solution around S∗5 .
Figure 5. Stability of S∗5 (a), S∗6 (b), and S∗8 (c), with parameter values from Table 1, except for β = 1.4
and σ2 = 1, so that β > dF. White area shows the region where the steady state is infeasible. Colour
code denotes max[Re(λ)] for each steady states when it is feasible. (d) Summary of stability results.
Green indicates the region where S∗6 and S∗8 are stable, and S∗5 is unstable, whereas red is the area
where S∗5 and S∗8 are stable, and S∗6 is infeasible. Yellow is where S∗8 is stable, S∗5 is unstable, and S∗6
is infeasible. Purple shows the region where S∗6 is stable, but S∗5 and S∗8 are unstable. Blue and cyan
indicate the regions where S∗5 and S∗6 are unstable, but S∗8 is stable or unstable, respectively.
Figure 6 illustrates the basins of attraction of the steady states S∗5 , S∗6 and S∗8 , as well as periodic
solutions around S∗8 . Figure 6a shows the basins of attraction of the steady states S∗5 and S∗8 and
demonstrates that if the initial number of regulatory T cells or infected cells is sufficiently high, or
the initial amount of infected cells is very low, the immune response neither eliminates infection nor
clears autoreactive T cells, and the system approaches the stable steady state S∗5 . Figure 6b illustrates
bi-stability between the stable steady state S∗6 and a periodic solution around S∗8 , and has a different
behaviour to than shown in Figure 6a. This figure suggests that for a specific range of F(0) the system
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converges to a stable autoimmune state S∗6 for all values of Treg(0). However, if the initial number of
infected cells is very high or very low, the system instead develops a periodic solution around the
steady state S∗8 associated with chronic infection.
Figure 6. Bi-stability analysis of the steady states S∗5 , S∗6 , and S∗8 with the same parameter values as in
Figure 5, except for (a) δ2 = 0.1, (b) δ2 = 0.02. Yellow indicates the basin of attraction of the chronic
steady state S∗8 , purple is the basin of attraction of periodic solutions around S∗8 . Red and pink are the
basins of attraction of the steady states S∗5 and S∗6 , respectively.
Figure 7 illustrates a regime of bi-stability between a stable steady state S∗6 and a periodic solution
around S∗8 for combinations of initial conditions indicated by crossed in Figure 6b. It also illustrates how
the system develops a stable solution around the steady state S∗8 for a higher value of τ2. This figure
shows that by increasing the initial number of infected cells the behaviour of the system changes, as it
then approaches the autoimmune steady state S∗6 . Interestingly, one can observe that for high values
of F(0) the system can eliminate the infection, but it cannot clear the autoreactive T cells, in which
case the system converges to S∗6 . On the other hand, for a smaller number of infected cells the system
develops a periodic solution around the endemic steady state.
Figure 8 shows how the stability of the chronic infection steady state S∗8 changes with respect
to time delays. Figure 8a indicates that for small values of τ2 (i.e., when the influence of IL-2 on
proliferation of T cells is occurring quite rapidly), the steady state S∗8 is stable, and increasing the time
delay τ1 associated with viral eclipse phase does not have an effect on its stability. At the same time,
if τ2 exceeds some specific value, by increasing τ1 the chronic steady state switches between being
stable or unstable. Figure 8b demonstrates a different behaviour, suggesting that for each value of
τ1, there is small range of τ3 values where S∗8 is stable, but for smaller and larger values of τ3 it is
unstable. For intermediate values of the eclipse phase delay τ1, there is an additional narrow range of
τ3 values where S∗8 is stable. Figure 8c illustrates that for very small, respectively very large, values of
τ3, the chronic infection steady state is stable, respectively unstable for any value of τ2; for intermediate
values of τ3, this steady state undergoes a finite number of stability switches for increasing values of τ2
and eventually becomes unstable.
It should be noted Figure 8 shows that unlike τ1 and τ2, once the steady state S∗8 loses stability via
Hopf bifurcation due to increasing τ3, it cannot regain stability for higher values of τ3.
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Figure 7. Numerical solutions of the model with same parameters values as Figure 6b. (a,b) Stable
steady state S∗6 for F(0) = 0.002 and Treg(0) = 200. (c,d) Periodic oscillations around the steady state
S∗8 for F(0) = 0.001 and Treg(0) = 200. (e,f) Transient oscillations settling on a stable steady state S∗8 for
τ2 = 25, F(0) = 0.001 and Treg(0) = 200.
Figure 8. Colour code denotes max[Re(λ)] for the endemic steady state S∗8 depending on (a) τ1 − τ2; (b)
τ1 − τ3; and (c) τ3 − τ2, with the parameter values taken from Table 1, except for β = 1.4, σ2 = 1, and
δ2 = 0.04.
5. Conclusions
In this paper, we have developed and analysed a time-delayed model of immune response to a
viral infection, which accounts for T cells with different activation thresholds, a cytokine mediating T cell
proliferation, as well as regulatory T cells. Particular attention is payed to the dual suppressive role
of regulatory T cells in terms of reducing the amount of autoreactive T cells, and also inhibiting IL-2.
To achieve better biological realism of the model, we have explicitly included time delays associated with
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the eclipse phase of the virus life cycle, stimulation/proliferation of T cells by IL-2, and suppression of
IL-2 by regulatory T cells. Depending on the values of parameters, the system can have four steady states:
the disease-free state, the state characterised by the death of host cells, the autoimmune state, and a state
of chronic infection. We have established conditions for stability and steady-state or Hopf bifurcations of
these steady states in terms of system parameters.
In the case where the natural death rate of infected cells exceeds the infection rate, the immune
system is able to clear the infection, and the disease-fee steady state is stable. In this regime, the system
can also support the autoimmune steady state or the steady state with the death of host cells, either of
which can be stable, or give rise to a periodic solution emerging via Hopf bifurcation. In the opposite
case, when the natural death rate of infected cells is smaller than the infection rate, the disease-fee
steady state is unstable, but it is possible to have a bi-stability between the other three steady states
or periodic solutions around them. To better understand bi-stability between different dynamical
regimes, we have used numerical simulations to identify basins of attraction of different steady states
and periodic solutions depending on the initial level of infection and the initial number of regulatory
T cells. The fact that for the same parameter values the system can exhibit bi-stability between a
disease-free steady state and an autoimmune state, represented by sustained periodic oscillations
following the clearance of infection, is very important from a clinical point of view, as effectively it
suggests that the progress and eventual outcome of viral infection is also determined by the strength
of infection and the initial state of the immune system. One counter-intuitive observation is that
in the case of bi-stability with a disease-free steady state, for higher initial numbers of regulatory T
cells, the autoimmune steady state is actually stable for a wider range of initial levels of infection.
In this regime of bi-stability, increasing the time delay associated with the positive impact of IL-2 on
proliferation of T cells results in the loss of stability of autoimmune steady state and emergence of
autoimmune dynamics, characterised by stable periodic oscillations. On the contrary, in the case where
the disease-free steady state is unstable, increasing this time delay results in stabilisation of the chronic
infection.
There are several directions in which the work presented in this paper can be extended. One direction
is exploration of the contributions from other components of immune response, more specifically,
antibodies and memory T cells, to the onset and progress of autoimmunity [69,70]. This is particularly
important from the perspective that clinically the onset of autoimmune disease is often taking place on
a much longer scale than the timescale of a regular immune response to a viral infection, so memory
T cells can be expected to play a more substantial role. While our model has focused on one specific
growth cytokine IL-2, a number of other cytokines, such as IL-7 [71], TNFβ and IL-10 [29], are known
to significantly affect homeostasis and proliferation of different types of T cells, as well as mediate
their efficiency in eliminating the infection. Including these immune mediators explicitly in the
model can provide further significant insights into the dynamics of immune response, as has been
recently demonstrated on the example of a detailed model of immune response to hepatitis B [72].
Another biologically relevant and mathematically challenging problem is the investigation of the interplay
between stochasticity, which is known to be an intrinsic feature of immune response [49,73], and effects of
time delays associated with various aspects of immune dynamics.
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Appendix A
Coefficients of Equation (7) for Hopf frequency are given below.
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b2 =
(
− δ14δ24ρ12Y2 + 2 dr2δ14δ24
)
T∗reg8 +
(
− 2 δ13δ23ρ1
(
daδ2ρ1 + diδ1ρ1 − 2 drδ2ρ3
)
I∗2 +
8 dr2δ13δ23
(
daδ2 + diδ1
))
T∗reg7 +
(
− 2 δ12δ23ρ12ρ3
(
4 δ1ρ1 + δ2ρ1 + 5 δ2ρ3
)
I∗4 − δ12δ22
(
da2δ22ρ12 +
2 dadiδ1δ2ρ12 − 8 dadrδ22ρ1ρ3 + di2δ12ρ12 − 12 didrδ1δ2ρ1ρ3 + 2 dr2δ12ρ12 + 2 dr2δ1δ2ρ12 + 6 dr2δ1δ2ρ1ρ3 +
dr2δ22ρ12 + 8 dr
2δ2
2ρ3
2
)
I∗2 + 2 dr2δ12δ22
(
6 da2δ22 + 16 dadiδ1δ2 + 6 di
2δ1
2 + dr2δ12 + dr
2δ2
2
))
T∗reg6 +(
− 2 ρ3δ22ρ1δ1
(
6 daδ1δ2ρ12 + 6 daδ22ρ1ρ3 + 9 diδ12ρ12 + 5 diδ1δ2ρ12 + 22 diδ1δ2ρ1ρ3 + 6 drδ12ρ12 +
2 drδ1δ2ρ12 − 4 drδ22ρ32
)
I∗4 + 2 δ1δ2
(
da2diδ1δ22ρ12 + 2 da
2drδ23ρ1ρ3 + dadi
2δ1
2δ2ρ1
2 + 10 dadidrδ1δ22ρ1ρ3 −
3 dadr2δ12δ2ρ12 − 2 dadr2δ1δ22ρ12 − 8 dadr2δ1δ22ρ1ρ3 − 8 dadr2δ23ρ32 + 6 di2drδ12δ2ρ1ρ3 − didr2δ13ρ12 −
3 didr
2δ1
2δ2ρ1
2 − 8 didr2δ12δ2ρ1ρ3 − didr2δ1δ22ρ12 − 2 didr2δ1δ22ρ1ρ3 − 16 didr2δ1δ22ρ32 + dr3δ12δ2ρ1ρ3 +
2 dr3δ1δ22ρ1ρ3 + 2 dr
3δ2
3ρ1ρ3
)
I∗2 + 4 dr2δ1δ2
(
2 da3δ23 + 12 da2diδ1δ22 + 12 dadi
2δ1
2δ2 + 2 dadr2δ12δ2 + dadr
2δ2
3 +
2 di
3δ1
3 + didr
2δ1
3 + 2 didr
2δ1δ2
2
))
T∗reg5 +
(
− 2 δ22ρ12ρ32
(
δ1
2ρ1
2 + δ1δ2ρ1
2 + 3 δ1δ2ρ1ρ3 + 2 δ22ρ32
)
I∗6 −
2 ρ3δ2ρ1
(
2 da2δ1δ22ρ12 + da
2δ2
3ρ1ρ3 + 9 dadiδ12δ2ρ12 + 24 dadiδ1δ22ρ1ρ3 + 12 dadrδ12δ2ρ12 − 4 dadrδ23ρ32 +
4 di
2δ1
3ρ1
2 + 8 di
2δ1
2δ2ρ1
2 + 33 di
2δ1
2δ2ρ1ρ3 + 9 didrδ13ρ12 + 9 didrδ12δ2ρ12 + 2 didrδ1δ22ρ12 − 20 didrδ1δ22ρ32 −
4 dr2δ12δ2ρ1ρ3 − 6 dr2δ1δ22ρ1ρ3 − 4 dr2δ1δ22ρ32 + dr2δ23ρ1ρ3 − 4 dr2δ23ρ32
)
I∗4 +
(
2 da3diδ1δ23ρ12 +
6 da2di
2δ1
2δ2
2ρ1
2 + 4 da2didrδ1δ23ρ1ρ3 − 7 da2dr2δ12δ22ρ12 − 2 da2dr2δ1δ23ρ12 − 14 da2dr2δ1δ23ρ1ρ3 −
8 da2dr2δ24ρ32 + 2 dadi
3δ1
3δ2ρ1
2 + 12 dadi
2drδ12δ22ρ1ρ3 − 6 dadidr2δ13δ2ρ12 − 12 dadidr2δ12δ22ρ12 −
42 dadidr
2δ1
2δ2
2ρ1ρ3 + 2 dadidr
2δ1δ2
3ρ1
2 − 8 dadidr2δ1δ23ρ1ρ3 − 64 dadidr2δ1δ23ρ32 + 2 dadr3δ12δ22ρ1ρ3 +
8 dadr3δ1δ23ρ1ρ3 + 4 di
3drδ13δ2ρ1ρ3 − di2dr2δ14ρ12 − 6 di2dr2δ13δ2ρ12 − 14 di2dr2δ13δ2ρ1ρ3 − 2 di2dr2δ12δ22ρ12 −
12 di
2dr2δ12δ22ρ1ρ3 − 48 di2dr2δ12δ22ρ32 + 10 didr3δ12δ22ρ1ρ3 + 12 didr3δ1δ23ρ1ρ3 − 5 dr4δ12δ22ρ32 −
4 dr4δ24ρ32
)
I∗2 + 2 dr2
(
da4δ24 + 16 da3diδ1δ23 + 36 da
2di
2δ1
2δ2
2 + 6 da2dr2δ12δ22 + da
2dr2δ24 + 16 dadi
3δ1
3δ2 +
8 dadidr
2δ1
3δ2 + 8 dadidr
2δ1δ2
3 + di
4δ1
4 + di
2dr2δ14 + 6 di
2dr2δ12δ22
))
T∗reg4 +
(
− 2 δ2ρ12ρ32
(
daδ1δ2ρ12 +
2 daδ22ρ1ρ3 + 2 diδ12ρ12 + 5 diδ1δ2ρ12 + 14 diδ1δ2ρ1ρ3 + 2 diδ22ρ1ρ3 + 12 diδ22ρ32 − drδ1δ2ρ1ρ3 −
2 drδ22ρ1ρ3
)
I∗6 + 2 ρ3ρ1
(
2 da2diδ1δ22ρ12 − 2 da2diδ23ρ1ρ3 − 7 da2drδ1δ22ρ12 + 4 dadi2δ12δ2ρ12 + 2 dadi2δ1δ22ρ12 −
30 dadi
2δ1δ2
2ρ1ρ3 − 15 dadidrδ12δ2ρ12 − 4 dadidrδ1δ22ρ12 + 20 dadidrδ23ρ32 + 8 dadr2δ1δ22ρ1ρ3 + 4 dadr2δ23ρ32 −
4 di
3δ1
2δ2ρ1
2 − 20 di3δ12δ2ρ1ρ3 − 2 di2drδ13ρ12 − 12 di2drδ12δ2ρ12 − 7 di2drδ1δ22ρ12 + 36 di2drδ1δ22ρ32 +
6 didr
2δ1
2δ2ρ1ρ3 + 20 didr
2δ1δ2
2ρ1ρ3 + 12 didr
2δ1δ2
2ρ3
2 − 2 didr2δ23ρ1ρ3 + 20 didr2δ23ρ32 + 3 dr3δ1δ22ρ32 −
4 dr3δ23ρ32
)
I∗4 +
(
2 da3di
2δ1δ2
2ρ1
2 − 4 da3didrδ23ρ1ρ3 − 4 da3dr2δ1δ22ρ12 − 4 da3dr2δ23ρ1ρ3 + 2 da2di3δ12δ2ρ12 −
12 da2di
2drδ1δ22ρ1ρ3 − 8 da2didr2δ12δ2ρ12 − 6 da2didr2δ1δ22ρ12 − 36 da2didr2δ1δ22ρ1ρ3 − 4 da2didr2δ23ρ1ρ3 −
32 da2didr
2δ2
3ρ3
2 − 2 da2dr3δ1δ22ρ1ρ3 + 4 da2dr3δ23ρ1ρ3 − 4 dadi3drδ12δ2ρ1ρ3 − 4 dadi2dr2δ13ρ12 −
12 dadi
2dr2δ12δ2ρ12 − 36 dadi2dr2δ12δ2ρ1ρ3 + 2 dadi2dr2δ1δ22ρ12 − 24 dadi2dr2δ1δ22ρ1ρ3 − 96 dadi2dr2δ1δ22ρ32 −
8 dadidr
3δ1
2δ2ρ1ρ3 + 20 dadidr
3δ1δ2
2ρ1ρ3 − 4 dadidr3δ23ρ1ρ3 − 10 dadr4δ1δ22ρ32 − 2 di3dr2δ13ρ12 −
4 di
3dr2δ13ρ1ρ3− 2 di3dr2δ12δ2ρ12− 12 di3dr2δ12δ2ρ1ρ3− 32 di3dr2δ12δ2ρ32− 2 di2dr3δ13ρ1ρ3 + 8 di2dr3δ12δ2ρ1ρ3 +
12 di
2dr3δ1δ22ρ1ρ3 − 10 didr4δ12δ2ρ32 − 16 didr4δ23ρ32
)
I∗2 + 8 dr2
(
da4diδ23 + 6 da
3di
2δ1δ2
2 + da3dr2δ1δ22 +
6 di
3δ1
2δ2da2 + 3 da2didr
2δ1
2δ2 + da2didr
2δ2
3 + dadi
4δ1
3 + dadi
2δ1
3dr2 + 3 dadi
2δ1dr
2δ2
2 + di
3δ1
2δ2dr2
))
T∗reg3 +(
2 δ22ρ14ρ34 I∗8 − ρ12ρ32
(
da2δ22ρ12 + 6 dadiδ1δ2ρ12 + 18 dadiδ22ρ1ρ3 + 2 dadrδ22ρ1ρ3 + 4 di
2δ1
2ρ1
2 +
16 di
2δ1δ2ρ1
2 + 40 di
2δ1δ2ρ1ρ3 + di
2δ2
2ρ1
2 + 20 di
2δ2
2ρ1ρ3 + 52 di
2δ2
2ρ3
2 + 4 didrδ1δ2ρ1ρ3 − 18 didrδ22ρ1ρ3 +
5 dr2δ22ρ32
)
I∗6 + 2 ρ1ρ3
(
2 da3diδ22ρ12 − da3drδ22ρ12 + 12 da2di2δ1δ2ρ12 + da2di2δ22ρ12 + 3 da2di2δ22ρ1ρ3 −
5 da2didrδ1δ2ρ12 − 2 da2didrδ22ρ12 + 4 da2dr2δ22ρ1ρ3 + 4 dadi3δ12ρ12 + 6 dadi3δ1δ2ρ12 − 12 dadi3δ1δ2ρ1ρ3 −
8 dadi
2drδ1δ2ρ12 + dadi
2drδ22ρ12 + 36 dadi
2drδ22ρ32 + 14 dadidr
2δ1δ2ρ1ρ3 + 12 dadidr
2δ2
2ρ3
2 + 3 dadr3δ22ρ32 −
4 di
4δ1
2ρ1ρ3 − 4 di3drδ12ρ12 − 7 di3drδ1δ2ρ12 + 28 di3drδ1δ2ρ32 + 3 di2dr2δ12ρ1ρ3 + 22 di2dr2δ1δ2ρ1ρ3 +
12 di
2dr2δ1δ2ρ32 + 3 di
2dr2δ22ρ1ρ3 + 36 di
2dr2δ22ρ32 + 9 didr
3δ1δ2ρ3
2 − 12 didr3δ22ρ32
)
I∗4 +
(
− da4di2δ22ρ12 −
da4dr2δ22ρ12 − 2 da3di3δ1δ2ρ12 − 12 da3di2drδ22ρ1ρ3 − 6 da3didr2δ1δ2ρ12 − 10 da3didr2δ22ρ1ρ3 − 2 da3dr3δ22ρ1ρ3 −
da2di
4δ1
2ρ1
2 − 20 da2di3drδ1δ2ρ1ρ3 − 7 da2di2dr2δ12ρ12 − 6 da2di2dr2δ1δ2ρ12 − 30 da2di2dr2δ1δ2ρ1ρ3 −
2 da2di
2dr2δ22ρ12 − 12 da2di2dr2δ22ρ1ρ3 − 48 da2di2dr2δ22ρ32 − 16 da2didr3δ1δ2ρ1ρ3 + 10 da2didr3δ22ρ1ρ3 −
5 da2dr4δ22ρ32 − 4 dadi4drδ12ρ1ρ3 − 4 dadi3dr2δ12ρ12 − 10 dadi3dr2δ12ρ1ρ3 − 2 dadi3dr2δ1δ2ρ12 −
24 dadi
3dr2δ1δ2ρ1ρ3 − 64 dadi3dr2δ1δ2ρ32 − 10 dadi2dr3δ12ρ1ρ3 + 16 dadi2dr3δ1δ2ρ1ρ3 − 12 dadi2dr3δ22ρ1ρ3 −
20 dadidr
4δ1δ2ρ3
2 − di4dr2δ12ρ12 − 4 di4dr2δ12ρ1ρ3 − 8 di4dr2δ12ρ32 + 2 di3dr3δ12ρ1ρ3 + 4 di3dr3δ1δ2ρ1ρ3 −
5 di
2dr4δ12ρ32 − 24 di2dr4δ22ρ32
)
I∗2 + 2 dr2
(
6 da4di
2δ2
2 + da4dr2δ22 + 16 da3di
3δ1δ2 + 8 da
3didr
2δ1δ2 +
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6 da2di
4δ1
2 + 6 da2di
2dr2δ12 + 6 da
2di
2dr2δ22 + 8 dadi
3dr2δ1δ2 + di
4dr2δ12
))
T∗reg2 +
(
8 diδ2ρ14ρ34 I∗8 −
4 diρ12ρ32
(
da2δ2ρ12 + 2 dadiδ1ρ12 + 6 dadiδ2ρ1ρ3 + 3 dadrδ2ρ1ρ3 + 2 di
2δ1ρ1
2 + 4 di
2δ1ρ1ρ3 + di
2δ2ρ1
2 +
8 di
2δ2ρ1ρ3 + 12 di
2δ2ρ3
2 + 2 didrδ1ρ1ρ3 − 6 didrδ2ρ1ρ3 + 3 dr2δ2ρ32
)
I∗6 + 2 diρ1ρ3
(
4 da3diδ2ρ12 + da
3drδ2ρ12 +
5 da2di
2δ1ρ1
2 + 3 da2di
2δ2ρ1
2 + 8 da2di
2δ2ρ1ρ3 + 5 da
2didrδ1ρ12 − 4 da2didrδ2ρ12 + 8 da2dr2δ2ρ1ρ3 + 4 dadi3δ1ρ12 −
2 dadi
2drδ1ρ12 + 3 dadi
2drδ2ρ12 + 28 dadi
2drδ2ρ32 + 8 dadidr
2δ1ρ1ρ3 + 12 dadidr
2δ2ρ3
2 + 9 dadr3δ2ρ32 −
2 di
3drδ1ρ12 + 8 di
3drδ1ρ32 + 8 di
2dr2δ1ρ1ρ3 + 4 di
2dr2δ1ρ32 + 8 di
2dr2δ2ρ1ρ3 + 28 di
2dr2δ2ρ32 + 6 didr
3δ1ρ3
2 −
12 didr
3δ2ρ3
2
)
I∗4 − 2 di
(
da4di
2δ2ρ1
2 + da4dr2δ2ρ12 + da
3di
3δ1ρ1
2 + 6 da3di
2drδ2ρ1ρ3 + 3 da
3didr
2δ1ρ1
2 +
4 da3didr
2δ2ρ1ρ3 + 4 da
3dr3δ2ρ1ρ3 + 4 da
2di
3drδ1ρ1ρ3 + da
2di
2dr2δ1ρ12 + 4 da
2di
2dr2δ1ρ1ρ3 + 2 da
2di
2dr2δ2ρ12 +
6 da2di
2dr2δ2ρ1ρ3 + 16 da
2di
2dr2δ2ρ32 + 7 da2didr
3δ1ρ1ρ3 − 4 da2didr3δ2ρ1ρ3 + 5 da2dr4δ2ρ32 + dadi3dr2δ1ρ12 +
4 dadi
3dr2δ1ρ1ρ3 + 8 dadi
3dr2δ1ρ32 − 2 dadi2dr3δ1ρ1ρ3 + 6 dadi2dr3δ2ρ1ρ3 + 5 dadidr4δ1ρ32 + 8 di2dr4δ2ρ32
)
I∗2 +
4 dadidr
2
(
2 da3di
2δ2 + da3dr2δ2 + 2 da2di
3δ1 + 2 da
2didr
2δ1 + 2 dadi
2dr2δ2 + di
3dr2δ1
))
T∗reg + 8 di2ρ14ρ34 I∗8 −
di
2ρ1
2ρ3
2
(
5 da2ρ12 + 8 dadiρ1ρ3 + 12 dadrρ1ρ3 + 4 di
2ρ1
2 + 16 di
2ρ1ρ3 + 16 di
2ρ3
2 − 8 didrρ1ρ3 + 8 dr2ρ32
)
I∗6 +
2 di
2ρ1ρ3
(
da3diρ12 + 3 da
3drρ12 + 2 da
2di
2ρ1
2 + 4 da2di
2ρ1ρ3 − da2didrρ12 + 5 da2dr2ρ1ρ3 + 2 dadi2drρ12 +
8 dadi
2drρ32 + 4 dadidr
2ρ3
2 + 6 dadr3ρ32 + 4 di
2dr2ρ1ρ3 + 8 di
2dr2ρ32 − 4 didr3ρ32
)
I∗4 − di2
(
da4di
2ρ1
2 +
2 da4dr2ρ12 + 4 da
3di
2drρ1ρ3 + 2 da
3didr
2ρ1ρ3 + 6 da
3dr3ρ1ρ3 + 2 da
2di
2dr2ρ12 + 4 da
2di
2dr2ρ1ρ3 + 8 da
2di
2dr2ρ32−
2 da2didr
3ρ1ρ3 + 5 da
2dr4ρ32 + 4 dadi
2dr3ρ1ρ3 + 4 di
2dr4ρ32
)
I∗2 + 2 da2di2dr2
(
da2di
2 + da2dr2 + di
2dr2
)
.
b4 = T∗reg8δ14δ24 + 4 δ13δ23 (daδ2 + diδ1) T∗reg7 +
(
− δ12δ22
(
2 δ12ρ12 + 2 δ1δ2ρ12 + 6 δ1δ2ρ1ρ3 + δ22ρ12 +
4 δ22ρ32
)
I∗2 + 2 δ12δ22
(
3 da2δ22 + 8 dadiδ1δ2 + 3 di
2δ1
2 + 2 dr2δ12 + 2 dr
2δ2
2
))
T∗reg6 +
(
− 2 δ1δ2
(
3 daδ12δ2ρ12 +
2 daδ1δ22ρ12 + 8 daδ1δ22ρ1ρ3 + 4 daδ23ρ32 + diδ13ρ12 + 3 diδ12δ2ρ12 + 8 diδ12δ2ρ1ρ3 + diδ1δ22ρ12 + 2 diδ1δ22ρ1ρ3 +
8 diδ1δ22ρ32 − drδ12δ2ρ1ρ3 − 2 drδ1δ22ρ1ρ3 − 2 drδ23ρ1ρ3
)
I∗2 + 4 δ1δ2
(
da3δ23 + 6 da2diδ1δ22 + 6 dadi
2δ1
2δ2 +
4 dadr2δ12δ2 + 2 dadr
2δ2
3 + di
3δ1
3 + 2 didr
2δ1
3 + 4 didr
2δ1δ2
2
))
T∗reg5 +
(
2 ρ3δ2ρ1
(
4 δ13ρ12 + 4 δ12δ2ρ1ρ3 −
2 δ1δ22ρ12 + 6 δ1δ22ρ1ρ3 + 4 δ1δ22ρ32 − δ23ρ1ρ3 + 4 δ23ρ32
)
Y4 +
(
− 7 da2δ12δ22ρ12 − 2 da2δ1δ23ρ12 −
14 da2δ1δ23ρ1ρ3 − 4 da2δ24ρ32 − 6 dadiδ13δ2ρ12 − 12 dadiδ12δ22ρ12 − 42 dadiδ12δ22ρ1ρ3 + 2 dadiδ1δ23ρ12 −
8 dadiδ1δ23ρ1ρ3 − 32 dadiδ1δ23ρ32 + 2 dadrδ12δ22ρ1ρ3 + 8 dadrδ1δ23ρ1ρ3 − di2δ14ρ12 − 6 di2δ13δ2ρ12 −
14 di
2δ1
3δ2ρ1ρ3 − 2 di2δ12δ22ρ12 − 12 di2δ12δ22ρ1ρ3 − 24 di2δ12δ22ρ32 + 10 didrδ12δ22ρ1ρ3 + 12 didrδ1δ23ρ1ρ3 −
dr2δ14ρ12 − 2 dr2δ13δ2ρ12 − 6 dr2δ13δ2ρ1ρ3 − 3 dr2δ12δ22ρ12 − 2 dr2δ12δ22ρ1ρ3 − 10 dr2δ12δ22ρ32 − 2 dr2δ1δ23ρ12 −
6 dr2δ1δ23ρ1ρ3 − 8 dr2δ24ρ32
)
I∗2 + da4δ24 + 16 da3diδ1δ23 + 36 da2di2δ12δ22 + 24 da2dr2δ12δ22 + 4 da2dr2δ24 +
16 dadi
3δ1
3δ2 + 32 dadidr
2δ1
3δ2 + 32 dadidr
2δ1δ2
3 + di
4δ1
4 + 4 di
2dr2δ14 + 24 di
2dr2δ12δ22 + dr
4δ1
4 + 4 dr4δ12δ22 +
dr4δ24
)
T∗reg4 +
(
2 ρ3ρ1
(
10 daδ12δ2ρ12 − 2 daδ1δ22ρ12 + 8 daδ1δ22ρ1ρ3 + 4 daδ23ρ32 + 3 diδ13ρ12 + 3 diδ12δ2ρ12 +
6 diδ12δ2ρ1ρ3 − 2 diδ1δ22ρ12 + 20 diδ1δ22ρ1ρ3 + 12 diδ1δ22ρ32 − 2 diδ23ρ1ρ3 + 20 diδ23ρ32 + drδ13ρ12 −
2 drδ12δ2ρ12− 5 drδ1δ22ρ12 + 3 drδ1δ22ρ32− 4 drδ23ρ32
)
I∗4 +
(
− 4 da3δ1δ22ρ12− 4 da3δ23ρ1ρ3− 8 da2diδ12δ2ρ12−
6 da2diδ1δ22ρ12 − 36 da2diδ1δ22ρ1ρ3 − 4 da2diδ23ρ1ρ3 − 16 da2diδ23ρ32 − 2 da2drδ1δ22ρ1ρ3 + 4 da2drδ23ρ1ρ3 −
4 dadi
2δ1
3ρ1
2 − 12 dadi2δ12δ2ρ12 − 36 dadi2δ12δ2ρ1ρ3 + 2 dadi2δ1δ22ρ12 − 24 dadi2δ1δ22ρ1ρ3 − 48 dadi2δ1δ22ρ32 −
8 dadidrδ12δ2ρ1ρ3 + 20 dadidrδ1δ22ρ1ρ3 − 4 dadidrδ23ρ1ρ3 − 4 dadr2δ13ρ12 − 4 dadr2δ12δ2ρ12 − 16 dadr2δ12δ2ρ1ρ3 −
4 dadr2δ1δ22ρ12 − 4 dadr2δ1δ22ρ1ρ3 − 20 dadr2δ1δ22ρ32 − 4 dadr2δ23ρ1ρ3 − 2 di3δ13ρ12 − 4 di3δ13ρ1ρ3 −
2 di
3δ1
2δ2ρ1
2 − 12 di3δ12δ2ρ1ρ3 − 16 di3δ12δ2ρ32 − 2 di2drδ13ρ1ρ3 + 8 di2drδ12δ2ρ1ρ3 + 12 di2drδ1δ22ρ1ρ3 −
2 didr
2δ1
3ρ1
2 − 4 didr2δ13ρ1ρ3 − 4 didr2δ12δ2ρ12 − 8 didr2δ12δ2ρ1ρ3 − 20 didr2δ12δ2ρ32 − 6 didr2δ1δ22ρ12 −
16 didr
2δ1δ2
2ρ1ρ3 − 4 didr2δ23ρ1ρ3 − 32 didr2δ23ρ32 − 2 dr3δ13ρ1ρ3 + 4 dr3δ12δ2ρ1ρ3 + 2 dr3δ1δ22ρ1ρ3 +
4 dr3δ23ρ1ρ3
)
I∗2 + 4 da4diδ23 + 24 da3di2δ1δ22 + 16 da3dr2δ1δ22 + 24 di3δ12δ2da2 + 48 da2didr2δ12δ2 +
16 da2didr
2δ2
3 + 4 dadi
4δ1
3 + 16 dadi
2δ1
3dr2 + 48 dadi
2δ1dr
2δ2
2 + 4 dadr4δ13 + 8 dadr
4δ1δ2
2 + 16 di
3δ1
2δ2dr2 +
8 didr
4δ1
2δ2 + 4 didr
4δ2
3
)
T∗reg3 +
(
− ρ12ρ32
(
δ1
2ρ1
2 + 2 δ1δ2ρ12 + 6 δ1δ2ρ1ρ3 + δ22ρ12 + 2 δ22ρ1ρ3 + 5 δ22ρ32
)
I∗6 +
2 ρ3ρ1
(
8 da2δ1δ2ρ12 − da2δ22ρ12 + 4 da2δ22ρ1ρ3 + 7 dadiδ12ρ12 + 2 dadiδ1δ2ρ12 + 14 dadiδ1δ2ρ1ρ3 + 2 dadiδ22ρ12 +
12 dadiδ22ρ32 + 3 dadrδ12ρ12 − 4 dadrδ1δ2ρ12 − dadrδ22ρ12 + 3 dadrδ22ρ32 + 4 di2δ12ρ12 + 3 di2δ12ρ1ρ3 +
4 di
2δ1δ2ρ1
2 + 22 di
2δ1δ2ρ1ρ3 + 12 di
2δ1δ2ρ3
2 + di
2δ2
2ρ1
2 + 3 di
2δ2
2ρ1ρ3 + 36 di
2δ2
2ρ3
2 − didrδ12ρ12 −
7 didrδ1δ2ρ12 + 9 didrδ1δ2ρ32 − 2 didrδ22ρ12 − 12 didrδ22ρ32 + dr2δ12ρ1ρ3 + 2 dr2δ1δ2ρ1ρ3 + 2 dr2δ1δ2ρ32 +
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4 dr2δ22ρ1ρ3 + 3 dr
2δ2
2ρ3
2
)
I∗4 +
(
− da4δ22ρ12 − 6 da3diδ1δ2ρ12 − 10 da3diδ22ρ1ρ3 − 2 da3drδ22ρ1ρ3 −
7 da2di
2δ1
2ρ1
2 − 6 da2di2δ1δ2ρ12 − 30 da2di2δ1δ2ρ1ρ3 − 2 da2di2δ22ρ12 − 12 da2di2δ22ρ1ρ3 − 24 da2di2δ22ρ32 −
16 da2didrδ1δ2ρ1ρ3 + 10 da
2didrδ22ρ1ρ3 − 6 da2dr2δ12ρ12 − 2 da2dr2δ1δ2ρ12 − 14 da2dr2δ1δ2ρ1ρ3 − 2 da2dr2δ22ρ12 −
2 da2dr2δ22ρ1ρ3 − 10 da2dr2δ22ρ32 − 4 dadi3δ12ρ12 − 10 dadi3δ12ρ1ρ3 − 2 dadi3δ1δ2ρ12 − 24 dadi3δ1δ2ρ1ρ3 −
32 dadi
3δ1δ2ρ3
2 − 10 dadi2drδ12ρ1ρ3 + 16 dadi2drδ1δ2ρ1ρ3 − 12 dadi2drδ22ρ1ρ3 − 4 dadidr2δ12ρ12 −
10 dadidr
2δ1
2ρ1ρ3 − 6 dadidr2δ1δ2ρ12 − 16 dadidr2δ1δ2ρ1ρ3 − 40 dadidr2δ1δ2ρ32 − 10 dadidr2δ22ρ1ρ3 −
6 dadr3δ12ρ1ρ3 + 8 dadr
3δ1δ2ρ1ρ3 − 2 dadr3δ22ρ1ρ3 − di4δ12ρ12 − 4 di4δ12ρ1ρ3 − 4 di4δ12ρ32 + 2 di3drδ12ρ1ρ3 +
4 di
3drδ1δ2ρ1ρ3 − 3 di2dr2δ12ρ12 − 6 di2dr2δ12ρ1ρ3 − 10 di2dr2δ12ρ32 − 6 di2dr2δ1δ2ρ12 − 14 di2dr2δ1δ2ρ1ρ3 −
di
2dr2δ22ρ12 − 12 di2dr2δ22ρ1ρ3 − 48 di2dr2δ22ρ32 + 2 didr3δ12ρ1ρ3 + 10 didr3δ22ρ1ρ3 − dr4δ12ρ32 −
5 dr4δ22ρ32
)
I∗2 + 6 da4di2δ22 + 4 da4dr2δ22 + 16 da3di3δ1δ2 + 32 da3didr2δ1δ2 + 6 da2di4δ12 + 24 da2di2dr2δ12 +
24 da2di
2dr2δ22 + 6 da2dr4δ12 + 4 da
2dr4δ22 + 32 dadi
3dr2δ1δ2 + 16 dadidr
4δ1δ2 + 4 di
4dr2δ12 + 4 di
2dr4δ12 +
6 di
2dr4δ22
)
T∗reg2 +
(
− 2 ρ12ρ32
(
daδ1ρ12 + 2 daδ2ρ1ρ3 + diδ1ρ12 + 2 diδ1ρ1ρ3 + 2 diδ2ρ12 + 6 diδ2ρ1ρ3 +
6 diδ2ρ32 + drδ1ρ1ρ3 − 2 drδ2ρ1ρ3
)
I∗6 + 2 ρ3ρ1
(
2 da3δ2ρ12 + 5 da
2diδ1ρ12 + da
2diδ2ρ12 + 8 da
2diδ2ρ1ρ3 +
3 da2drδ1ρ12 − 2 da2drδ2ρ12 + 6 dadi2δ1ρ12 + 8 dadi2δ1ρ1ρ3 + 4 dadi2δ2ρ12 + 12 dadi2δ2ρ32 − 2 dadidrδ1ρ12 +
dadidrδ2ρ12 + 9 dadidrδ2ρ32 + 2 dadr
2δ1ρ1ρ3 + 2 dadr
2δ2ρ3
2 + 3 di
3δ1ρ1
2 + 8 di
3δ1ρ1ρ3 + 4 di
3δ1ρ3
2 + 3 di
3δ2ρ1
2 +
8 di
3δ2ρ1ρ3 + 28 di
3δ2ρ3
2 − di2drδ1ρ12 + 6 di2drδ1ρ32 − 4 di2drδ2ρ12 − 12 di2drδ2ρ32 + 2 didr2δ1ρ1ρ3 + didr2δ1ρ32 +
8 didr
2δ2ρ1ρ3 + 9 didr
2δ2ρ3
2 + dr3δ1ρ32 − 2 dr3δ2ρ32
)
I∗4 +
(
− 2 da4diδ2ρ12 − 6 da3di2δ1ρ12 − 8 da3di2δ2ρ1ρ3 −
8 da3didrδ2ρ1ρ3 − 4 da3dr2δ1ρ12 − 4 da3dr2δ2ρ1ρ3 − 2 da2di3δ1ρ12 − 8 da2di3δ1ρ1ρ3 − 4 da2di3δ2ρ12 −
12 da2di
3δ2ρ1ρ3 − 16 da2di3δ2ρ32 − 14 da2di2drδ1ρ1ρ3 + 8 da2di2drδ2ρ1ρ3 − 2 da2didr2δ1ρ12 − 8 da2didr2δ1ρ1ρ3 −
4 da2didr
2δ2ρ1
2 − 8 da2didr2δ2ρ1ρ3 − 20 da2didr2δ2ρ32 − 6 da2dr3δ1ρ1ρ3 + 4 da2dr3δ2ρ1ρ3 − 2 dadi4δ1ρ12 −
8 dadi
4δ1ρ1ρ3 − 8 dadi4δ1ρ32 + 4 dadi3drδ1ρ1ρ3 − 12 dadi3drδ2ρ1ρ3 − 6 dadi2dr2δ1ρ12 − 12 dadi2dr2δ1ρ1ρ3 −
20 dadi
2dr2δ1ρ32 − 8 dadi2dr2δ2ρ1ρ3 + 4 dadidr3δ1ρ1ρ3 − 8 dadidr3δ2ρ1ρ3 − 2 dadr4δ1ρ32 − 2 di3dr2δ1ρ12 −
4 di
3dr2δ1ρ1ρ3 − 2 di3dr2δ2ρ12 − 12 di3dr2δ2ρ1ρ3 − 32 di3dr2δ2ρ32 − 2 di2dr3δ1ρ1ρ3 + 8 di2dr3δ2ρ1ρ3 −
10 didr
4δ2ρ3
2
)
I∗2 + 4 da4di3δ2 + 8 da4didr2δ2 + 4 da3di4δ1 + 16 da3di2dr2δ1 + 4 da3dr4δ1 + 16 da2di3dr2δ2 +
8 da2didr
4δ2 + 8 dadi
4dr2δ1 + 8 dadi
2dr4δ1 + 4 di
3dr4δ2
)
T∗reg + I∗8ρ14ρ34 − ρ12ρ32
(
da2ρ12 + 2 dadiρ1ρ3 +
2 dadrρ1ρ3 + 5 di
2ρ1
2 + 12 di
2ρ1ρ3 + 8 di
2ρ3
2 − 2 didrρ1ρ3 + dr2ρ32
)
I∗6 + 2 ρ3ρ1
(
da3diρ12 + da
3drρ12 +
3 da2di
2ρ1
2 + 5 da2di
2ρ1ρ3 − da2didrρ12 + da2dr2ρ1ρ3 + dadi3ρ12 + 4 dadi3ρ32 + 3 dadi2drρ12 + 6 dadi2drρ32 +
dadidr
2ρ3
2 + dadr3ρ32 + 2 di
4ρ1
2 + 4 di
4ρ1ρ3 + 8 di
4ρ3
2 − di3drρ12 − 4 di3drρ32 + 5 di2dr2ρ1ρ3 + 6 di2dr2ρ32 −
didr
3ρ3
2
)
I∗4 +
(
− 2 da4di2ρ12 − da4dr2ρ12 − 2 da3di3ρ1ρ3 − 6 da3di2drρ1ρ3 − 2 da3didr2ρ1ρ3 − 2 da3dr3ρ1ρ3 −
2 da2di
4ρ1
2 − 4 da2di4ρ1ρ3 − 4 da2di4ρ32 + 2 da2di3drρ1ρ3 − 4 da2di2dr2ρ12 − 6 da2di2dr2ρ1ρ3 − 10 da2di2dr2ρ32 +
2 da2didr
3ρ1ρ3 − da2dr4ρ32 − 4 dadi4drρ1ρ3 − 2 dadi3dr2ρ1ρ3 − 6 dadi2dr3ρ1ρ3 − di4dr2ρ12 − 4 di4dr2ρ1ρ3 −
8 di
4dr2ρ32 + 2 di
3dr3ρ1ρ3 − 5 di2dr4ρ32
)
I∗2 + da4di4 + 4 da4di2dr2 + da4dr4 + 4 da2di4dr2 + 4 da2di2dr4 + di4dr4.
b6 = 2 δ12δ22
(
δ1
2 + δ2
2
)
T∗reg6 + 4 δ1δ2
(
2 daδ12δ2 + daδ23 + diδ13 + 2 diδ1δ22
)
T∗reg5 +
((
− δ14ρ12 −
2 δ13δ2ρ12 − 6 δ13δ2ρ1ρ3 − 3 δ12δ22ρ12 − 2 δ12δ22ρ1ρ3 − 5 δ12δ22ρ32 − 2 δ1δ23ρ12 − 6 δ1δ23ρ1ρ3 − 4 δ24ρ32
)
I∗2 +
12 da2δ12δ22 + 2 da
2δ2
4 + 16 dadiδ13δ2 + 16 dadiδ1δ23 + 2 di
2δ1
4 + 12 di
2δ1
2δ2
2 + 2 dr2δ14 + 8 dr
2δ1
2δ2
2 +
2 dr2δ24
)
T∗reg4 +
((
− 4 daδ13ρ12− 4 daδ12δ2ρ12− 16 daδ12δ2ρ1ρ3− 4 daδ1δ22ρ12− 4 daδ1δ22ρ1ρ3− 10 daδ1δ22ρ32−
4 daδ23ρ1ρ3 − 2 diδ13ρ12 − 4 diδ13ρ1ρ3 − 4 diδ12δ2ρ12 − 8 diδ12δ2ρ1ρ3 − 10 diδ12δ2ρ32 − 6 diδ1δ22ρ12 −
16 diδ1δ22ρ1ρ3 − 4 diδ23ρ1ρ3 − 16 diδ23ρ32 − 2 drδ13ρ1ρ3 + 4 drδ12δ2ρ1ρ3 + 2 drδ1δ22ρ1ρ3 + 4 drδ23ρ1ρ3
)
I∗2 +
8 da3δ1δ22 + 24 da
2diδ12δ2 + 8 da
2diδ23 + 8 dadi
2δ1
3 + 24 dadi
2δ1δ2
2 + 8 dadr2δ13 + 16 dadr
2δ1δ2
2 + 8 di
3δ1
2δ2 +
16 didr
2δ1
2δ2 + 8 didr
2δ2
3
)
T∗reg3 +
(
2 ρ1ρ3
(
δ1
2ρ1
2 + δ1
2ρ1ρ3 + 4 δ1δ2ρ12 + 2 δ1δ2ρ1ρ3 + 2 δ1δ2ρ32 − δ22ρ12 +
4 δ22ρ1ρ3 + 3 δ22ρ32
)
I∗4 +
(
− 6 da2δ12ρ12 − 2 da2δ1δ2ρ12 − 14 da2δ1δ2ρ1ρ3 − 2 da2δ22ρ12 − 2 da2δ22ρ1ρ3 −
5 da2δ22ρ32 − 4 dadiδ12ρ12 − 10 dadiδ12ρ1ρ3 − 6 dadiδ1δ2ρ12 − 16 dadiδ1δ2ρ1ρ3 − 20 dadiδ1δ2ρ32 − 10 dadiδ22ρ1ρ3 −
6 dadrδ12ρ1ρ3 + 8 dadrδ1δ2ρ1ρ3 − 2 dadrδ22ρ1ρ3 − 3 di2δ12ρ12 − 6 di2δ12ρ1ρ3 − 5 di2δ12ρ32 − 6 di2δ1δ2ρ12 −
14 di
2δ1δ2ρ1ρ3 − di2δ22ρ12 − 12 di2δ22ρ1ρ3 − 24 di2δ22ρ32 + 2 didrδ12ρ1ρ3 + 10 didrδ22ρ1ρ3 − 2 dr2δ12ρ12 −
2 dr2δ12ρ1ρ3 − 2 dr2δ12ρ32 − 2 dr2δ1δ2ρ12 − 6 dr2δ1δ2ρ1ρ3 − dr2δ22ρ12 − 2 dr2δ22ρ1ρ3 − 10 dr2δ22ρ32
)
I∗2 +
2 da4δ22 + 16 da3diδ1δ2 + 12 da
2di
2δ1
2 + 12 da2di
2δ2
2 + 12 da2dr2δ12 + 8 da
2dr2δ22 + 16 dadi
3δ1δ2 + 32 dadidr
2δ1δ2 +
2 di
4δ1
2 + 8 di
2dr2δ12 + 12 di
2dr2δ22 + 2 dr4δ12 + 2 dr
4δ2
2
)
T∗reg2 +
(
2 ρ1ρ3
(
2 daδ1ρ12 + 2 daδ1ρ1ρ3 + 2 daδ2ρ12 +
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2 daδ2ρ32 + 3 diδ1ρ12 + 2 diδ1ρ1ρ3 + diδ1ρ32 + diδ2ρ12 + 8 diδ2ρ1ρ3 + 9 diδ2ρ32 + drδ1ρ12 + drδ1ρ32 − 2 drδ2ρ12 −
2 drδ2ρ32
)
I∗4 +
(
− 4 da3δ1ρ12 − 4 da3δ2ρ1ρ3 − 2 da2diδ1ρ12 − 8 da2diδ1ρ1ρ3 − 4 da2diδ2ρ12 − 8 da2diδ2ρ1ρ3 −
10 da2diδ2ρ32 − 6 da2drδ1ρ1ρ3 + 4 da2drδ2ρ1ρ3 − 6 dadi2δ1ρ12 − 12 dadi2δ1ρ1ρ3 − 10 dadi2δ1ρ32 − 8 dadi2δ2ρ1ρ3 +
4 dadidrδ1ρ1ρ3 − 8 dadidrδ2ρ1ρ3 − 4 dadr2δ1ρ12 − 4 dadr2δ1ρ1ρ3 − 4 dadr2δ1ρ32 − 4 dadr2δ2ρ1ρ3 − 2 di3δ1ρ12 −
4 di
3δ1ρ1ρ3 − 2 di3δ2ρ12 − 12 di3δ2ρ1ρ3 − 16 di3δ2ρ32 − 2 di2drδ1ρ1ρ3 + 8 di2drδ2ρ1ρ3 − 2 didr2δ1ρ12 −
4 didr
2δ1ρ1ρ3 − 2 didr2δ2ρ12 − 8 didr2δ2ρ1ρ3 − 20 didr2δ2ρ32 − 2 dr3δ1ρ1ρ3 + 4 dr3δ2ρ1ρ3
)
Y2 + 4 da4diδ2 +
8 da3di
2δ1 + 8 da
3dr2δ1 + 8 da
2di
3δ2 + 16 da2didr
2δ2 + 4 dadi
4δ1 + 16 dadi
2dr2δ1 + 4 dadr
4δ1 + 8 di
3dr2δ2 +
4 didr
4δ2
)
T∗reg − ρ12ρ32
(
ρ1 + ρ3
)2
I∗6 + 2 ρ1ρ3
(
da2ρ12 + da
2ρ1ρ3 + dadiρ12 + dadiρ32 + dadrρ12 + dadrρ32 +
3 di
2ρ1
2 + 5 di
2ρ1ρ3 + 6 di
2ρ3
2 − didrρ12 − didrρ32 + dr2ρ1ρ3 + dr2ρ32
)
Y4 +
(
− da4ρ12 − 2 da3diρ1ρ3 −
2 da3drρ1ρ3− 4 da2di2ρ12− 6 da2di2ρ1ρ3− 5 da2di2ρ32 + 2 da2didrρ1ρ3− 2 da2dr2ρ12− 2 da2dr2ρ1ρ3− 2 da2dr2ρ32−
2 dadi
3ρ1ρ3 − 6 dadi2drρ1ρ3 − 2 dadidr2ρ1ρ3 − 2 dadr3ρ1ρ3 − di4ρ12 − 4 di4ρ1ρ3 − 4 di4ρ32 + 2 di3drρ1ρ3 −
2 di
2dr2ρ12− 6 di2dr2ρ1ρ3− 10 di2dr2ρ32 + 2 didr3ρ1ρ3− dr4ρ32
)
I∗2 + 2 da4di2 + 2 da4dr2 + 2 da2di4 + 8 da2di2dr2 +
2 da2dr4 + 2 di
4dr2 + 2 di
2dr4.
b8 =
(
δ1
4 + 4 δ12δ22 + δ24
)
T∗reg4 +
(
4 daδ13 + 8 daδ1δ22 + 8 diδ12δ2 + 4 diδ23
)
T∗reg3 +
((
− 2 δ12ρ12 −
2 δ12ρ1ρ3− δ12ρ32− 2 δ1δ2ρ12− 6 δ1δ2ρ1ρ3− δ22ρ12− 2 δ22ρ1ρ3− 5 δ22ρ32
)
I∗2 + 6 da2δ12 + 4 da2δ22 + 16 dadiδ1δ2 +
4 di
2δ1
2 + 6 di
2δ2
2 + 4 dr2δ12 + 4 dr
2δ2
2
)
T∗reg2 +
((
− 4 daδ1ρ12− 4 daδ1ρ1ρ3− 2 daδ1ρ32− 4 daδ2ρ1ρ3− 2 diδ1ρ12−
4 diδ1ρ1ρ3 − 2 diδ2ρ12 − 8 diδ2ρ1ρ3 − 10 diδ2ρ32 − 2 drδ1ρ1ρ3 + 4 drδ2ρ1ρ3
)
I∗2 + 4 da3δ1 + 8 da2diδ2 + 8 dadi2δ1 +
8 dadr2δ1 + 4 di
3δ2 + 8 didr
2δ2
)
T∗reg + 2 ρ1ρ3
(
ρ1
2 + ρ3ρ1 + ρ3
2
)
I∗4 +
(
− 2 da2ρ12 − 2 da2ρ1ρ3 − da2ρ32 −
2 dadiρ1ρ3 − 2 dadrρ1ρ3 − 2 di2ρ12 − 6 di2ρ1ρ3 − 5 di2ρ32 + 2 didrρ1ρ3 − dr2ρ12 − 2 dr2ρ1ρ3 − 2 dr2ρ32
)
I∗2 + da4 +
4 da2di
2 + 4 da2dr2 + di
4 + 4 di
2dr2 + dr4.
b10 =
(
2 δ12 + 2 δ22
)
T∗reg2 +
(
4 daδ1 + 4 diδ2
)
Treg∗ −
(
ρ1 + ρ3
)2
I∗2 + 2 da2 + 2 di2 + 2 dr2.
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